According to DESPP, this quarterly report is how they plant to distribute this crime data hoping it will offer clarity and context for police departments and organizations around the state when ...

What to know: Ripple will end its current quarterly XRP markets reports after Q2 2025, promising more detailed insights as institutional demand grows. The Q1 2025 report noted XRP's strong ...

Reddit’s Q1 2025 earnings report highlights strong year-over-year growth in both logged-in and logged-out user activity, with usage rising significantly in the U.S. and even higher internationally.

Sydney, Australia--(Newsfile Corp. - April 29, 2025) - Established gold producer Austral Gold Limited's (ASX: AGD) (TSXV: AGLD) (OTCQB: AGLDF) (Austral or the Company) is pleased to announce that ...

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammator ...

Sydney, Australia-- (Newsfile Corp. - April 29, 2025) - Established gold producer Austral Gold Limited's (ASX: AGD) (TSXV: AGLD) (OTCQB: AGLDF) (Austral or the Company) is pleased to announce that ...

Quarterly Activity Report | Regulatory NewsAs announced on 24 February 2025, MMCI has signed a binding term sheet with Maharlika Investment Corporation, the Philippine's sovereign wealth fund, for ...

Fees to Non-Executive Directors were US$50,306, consulting payments to Non-Executive Directors were Nil and salary payments to full-time Executive Directors were US$223,092, detailed in Item 6 of the ...

Fees to Non-Executive Directors were US$50,306, consulting payments to Non-Executive Directors were Nil and salary payments to full-time Executive Directors were US$223,092, detailed in Item 6 of the ...

Hospital mergers and acquisitions dropped in the first quarter as the economic and political climate changed, according to Kaufman Hall’s “ M&A Quarterly Activity Report: Q1 2025.” There ...

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent ...